Granzyme a deficiency breaks immune tolerance and promotes autoimmune diabetes through a Type i interferon-dependent pathway

Zia U.A. Mollah, Hong Sheng Quah, Kate L. Graham, Gaurang Jhala, Balasubramanian Krishnamurthy, Joanna Francisca M. Dharma, Jonathan Chee, Prerak M. Trivedi, Evan G. Pappas, Leanne Mackin, Edward P.F. Chu, Satoru Akazawa, Stacey Fynch, Charlotte Hodson, Andrew J. Deans, Joseph A. Trapani, Mark M.W. Chong, Phillip I. Bird, Thomas C. Brodnicki, Helen E. ThomasThomas W.H. Kay

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

Granzyme A is a protease implicated in the degradation of intracellular DNA. Nucleotide complexes are known triggers of systemic autoimmunity, but a role in organ-specific autoimmune disease has not been demonstrated. To investigate whether such a mechanism could be an endogenous trigger for autoimmunity, we examined the impact of granzyme A deficiency in the NOD mouse model of autoimmune diabetes. Granzyme A deficiency resulted in an increased incidence in diabetes associated with accumulation of ssDNA in immune cells and induction of an interferon response in pancreatic islets. Central tolerance to proinsulin in transgenic NOD mice was broken on a granzyme A-deficient background. We have identified a novel endogenous trigger for autoimmune diabetes and an in vivo role for granzyme A in maintaining immune tolerance.

Original languageEnglish
Pages (from-to)3041-3050
Number of pages10
JournalDiabetes
Volume66
Issue number12
DOIs
Publication statusPublished - 1 Dec 2017

Cite this